PNC gains M&A bargaining chip as president departs
That's changed: Lyons is acknowledged heir apparent at a giant fintech where he'll become CEO by July at the latest.
Initial public offerings scheduled to debut next week
NEW YORK (AP) — The following is a list of initial public offerings planned for the coming week. Sources include IPO ETF manager Renaissance Capital, and SEC filings.
Piper Sandler cuts City Holding stock price target to $125
Piper Sandler adjusted its price target on City Holding (NASDAQ:CHCO) shares, bringing it down to $125 from the previous $135 while maintaining a Neutral rating. The $1.75 billion regional bank, ...
Travelers shares rise following Piper Sandler upgrade
Shares of Travelers (NYSE: NYSE:TRV) climbed 1% as Piper Sandler shifted its stance on the insurance giant, upgrading the stock from Neutral to Overweight and significantly raising the price target ...
Piper Sandler Remains a Hold on HBT Financial (HBT)
Piper Sandler analyst Nathan Race maintained a Hold rating on HBT Financial (HBT – Research Report) today and set a price target of $26.00. The ...
Piper Sandler Reaffirms Their Hold Rating on PayPal Holdings (PYPL)
In a report released today, Arvind Ramnani from Piper Sandler maintained a Hold rating on PayPal Holdings (PYPL – Research Report), with a ...
Piper Sandler raises Travelers stock rating, target to $310
Travelers Companies Inc. (NYSE:TRV), a $54.7 billion insurance giant trading at 11.5x earnings, received an upgrade in its ...
bovnews1d
ChampionX Corp (CHX) Stock: A Deeper Look at Its True Potential
ChampionX Corp (CHX) stock saw a decline, ending the day at $29.69 which represents a decrease of $-1.58 or -5.05% from the prior close of $31.27. The stock opened at $31.08 and touched a low of ...
American Banker1d
How Fiserv's new CEO shakes up succession at two firms
The technology vendor is going outside the company to hire PNC vet Michael Lyons to replace Trump administration-bound Frank Bisignano, leaving the Pittsburgh-bank without its heir apparent for the ...
bovnews1d
Akebia Therapeutics Inc (AKBA) Stock Settles at $2.39: What’s Contributing to This Price Point?
Akebia Therapeutics Inc (AKBA) stock saw a modest uptick, ending the day at $2.39 which represents a slight increase of $0.02 or 0.84% from the prior close of $2.37. The stock opened at $2.4 and ...
1TSLA : Tesla Set For A 'Choppy' First Half Amid New EV Policies, But This...
Elon Musk's Tesla could deliver a choppy H1 given tailwinds from Donald Trump's EV policies, uncertainties in deliveries, and gross margin.
Tesla's 'Trump bump' fades as stock falls alongside rest of EV sector
Tesla's stock shed early gains Tuesday that came after Trump's move to end the 'EV mandate' Tesla Inc.'s stock shed early gains Tuesday that came on expectations that Chief Executive Elon Musk's close ...